What does the evidence say about Lavender Sleep Onset Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Lavender Sleep Onset Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - This shift has been driven by increasing clinical and preclinical evidence supporting anxiolytic effects of standardizedessential oil preparations. [Nechepurenko Viktoriia (2026); evidence level 3] - Nevertheless, interest in its cultivation has increased significantly in recent years. [Nechepurenko Viktoriia (2026); evidence level 3] - The review seeks to integrate evidence on both volatile and nonvolatile fractions and to highlight opportunities for the valorization of lavender biomass within a sustainable, multi-sectoral framework. [Nechepurenko Viktoriia (2026); evidence level 3] - angustifolia Lavandula latifolia Lavender (genusL., family Lamiaceae) is one of the most extensively studied aromatic and medicinal plants. [Nechepurenko Viktoriia (2026); evidence level 3] - While its pathogenesis is complex, increasing evidence supports the role of an imbalance between excitatory and inhibitory (E/I) neuronal activity in disease progression. [Piccialli I (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.